NCT01723800: PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer |
|
|
| Completed | 1 | 9 | US | PI3K inhibitor BKM120, BKM120, PI3K_Inhibitor_BKM120, Buparlisib, pemetrexed disodium, ALIMTA, LY231514, MTA, carboplatin, Carboplat, CBDCA, JM-8, Paraplat, Paraplatin, laboratory biomarker analysis, pharmacological study, pharmacological studies, quality-of-life assessment, quality of life assessment | City of Hope Medical Center, National Cancer Institute (NCI) | Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | 09/16 | 09/16 | | |
